Adherence therapy for people with schizophrenia in Suanprung Psychiatric Hospital, Thailand: a randomised controlled trial
| ISRCTN | ISRCTN74277581 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN74277581 |
| ClinicalTrials.gov (NCT) | Nil known |
| Clinical Trials Information System (CTIS) | Nil known |
| Protocol serial number | N/A |
| Sponsor | The Royal Thai Government |
| Funder | Praboromarajanok Institute of Workforce Development (Thailand) |
- Submission date
- 24/10/2005
- Registration date
- 26/04/2006
- Last edited
- 20/01/2020
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Richard Gray
Scientific
Scientific
P O Box 30
De Crespigny Park
Denmark Hill
London
SE5 8AF
United Kingdom
| Phone | +44 (0)207 848 0139 |
|---|---|
| r.gray@iop.kcl.ac.uk |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Scientific title | Adherence therapy for people with schizophrenia in Suanprung Psychiatric Hospital, Thailand: a randomised controlled trial |
| Study objectives | Adherence therapy can reduce symptoms, increase attitude and satisfaction towards medication treatment |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Schizophrenia |
| Intervention | Treatment group: adherence therapy Control group: treatment as usual such as medication treatment, group counselling, occupational and recreational therapy |
| Intervention type | Other |
| Primary outcome measure(s) |
Symptoms of schizophrenia measured using the positive and negative syndrome scale |
| Key secondary outcome measure(s) |
1. Symptoms of schizophrenia measured using the Global Assessment of Functioning Scale |
| Completion date | 31/08/2005 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Sex | All |
| Target sample size at registration | 70 |
| Total final enrolment | 32 |
| Key inclusion criteria | 1. Patients diagnosed by a psychiatrist with schizophrenia according to ICD-10 criteria (World Health Organisation ([WHO], 1992) 2. People with schizophrenia who are older than 20 years of age because they have reached the age of maturity legally and can provide consent independently 3. People with schizophrenia who have been assessed by a psychiatrist not involved in this study to determine that they can provide informed consent 4. People with schizophrenia who are residing in Muang Chiang Mai district |
| Key exclusion criteria | Patients suffering from organic brain diseases or learning disability |
| Date of first enrolment | 01/12/2004 |
| Date of final enrolment | 31/08/2005 |
Locations
Countries of recruitment
- United Kingdom
- England
- Thailand
Study participating centre
P O Box 30
London
SE5 8AF
United Kingdom
SE5 8AF
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 01/07/2007 | 31/05/2019 | Yes | No |
Editorial Notes
20/01/2020: Internal review.
31/05/2019: Publication reference and total final enrolment added.
